Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB16548 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB16548, RRID:AB_10678335
- Product name
- ACVR1 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of ACVR1.
- Storage
- Store at 4°C for three months. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Activin isoforms signal through type I receptor serine/threonine kinase ALK7.
The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF beta superfamily from rat brain.
Tsuchida K, Nakatani M, Yamakawa N, Hashimoto O, Hasegawa Y, Sugino H
Molecular and cellular endocrinology 2004 May 31;220(1-2):59-65
Molecular and cellular endocrinology 2004 May 31;220(1-2):59-65
The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
Reissmann E, Jörnvall H, Blokzijl A, Andersson O, Chang C, Minchiotti G, Persico MG, Ibáñez CF, Brivanlou AH
Genes & development 2001 Aug 1;15(15):2010-22
Genes & development 2001 Aug 1;15(15):2010-22
Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF beta superfamily from rat brain.
Tsuchida K, Sawchenko PE, Nishikawa S, Vale WW
Molecular and cellular neurosciences 1996 Jun;7(6):467-78
Molecular and cellular neurosciences 1996 Jun;7(6):467-78
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of ACVR1 in human kidney tissue lysate with ACVR1 polyclonal antibody (Cat # PAB16548) at 1 ug/mL in (Lane 1) the absence and (Lane 2) the presence of blocking peptide.
